Cellectar Biosciences Inc (CLRB)

May 05, 2025

Cellectar Biosciences (NASDAQ:CLRB) Coverage Initiated by Analysts at StockNews.com - Defense World

May 05, 2025

May 01, 2025

It makes sense and dollars to buy Cellectar Biosciences Inc (CLRB) stock - Sete News

May 01, 2025

May 01, 2025

Cellectar Biosciences (CLRB) Considers Strategic Options to Enha - GuruFocus

May 01, 2025

May 01, 2025

Cellectar Announces Plan to Explore Strategic Alternatives | CLR - GuruFocus

May 01, 2025

Apr 30, 2025

Cellectar Biosciences Inc (CLRB) Stock: A Year of Highs and Lows in the Market - investchronicle.com

Apr 30, 2025

Apr 30, 2025

Checking in on Cellectar Biosciences Inc (CLRB) after recent insiders movement - knoxdaily.com

Apr 30, 2025

Apr 30, 2025

CLRB’s earnings estimates: Are they on track to meet expectations? - uspostnews.com

Apr 30, 2025

Apr 30, 2025

Cellectar explores strategic options to enhance shareholder value - Investing.com

Apr 30, 2025

Apr 30, 2025

Cellectar Announces Plan to Explore Strategic Alternatives - The Manila Times

Apr 30, 2025

Apr 30, 2025

Cellectar Explores Sale Options: Promising Cancer Drug Pipeline Attracts Strategic Review - Stock Titan

Apr 30, 2025

Apr 29, 2025

Financial Metrics Unveiled: Cellectar Biosciences Inc (CLRB)’s Key Ratios in the Spotlight - DWinneX

Apr 29, 2025

Apr 27, 2025

Cellectar Biosciences (NASDAQ:CLRB) Earns Sell Rating from Analysts at StockNews.com - Defense World

Apr 27, 2025

Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Apr 19, 2025

Cellectar Biosciences (NASDAQ:CLRB) Stock Price Passes Below 200-Day Moving Average – What’s Next? - Defense World

Apr 19, 2025

Apr 19, 2025

StockNews.com Initiates Coverage on Cellectar Biosciences (NASDAQ:CLRB) - Defense World

Apr 19, 2025

Apr 09, 2025

Sarepta Therapeutics (NASDAQ:SRPT) versus Cellectar Biosciences (NASDAQ:CLRB) Financial Analysis - Defense World

Apr 09, 2025

Apr 03, 2025

Cellectar Biosciences (NASDAQ:CLRB) Coverage Initiated at StockNews.com - Defense World

Apr 03, 2025

Mar 31, 2025

Financial Contrast: Cellectar Biosciences (NASDAQ:CLRB) versus Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Mar 31, 2025

Mar 26, 2025

Cellectar Biosciences (NASDAQ:CLRB) Now Covered by StockNews.com - Defense World

Mar 26, 2025

Mar 19, 2025

Cellectar Biosciences (CLRB) to Release Earnings on Wednesday - Defense World

Mar 19, 2025

Mar 18, 2025

Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 18, 2025

Mar 18, 2025

StockNews.com Begins Coverage on Cellectar Biosciences (NASDAQ:CLRB) - Defense World

Mar 18, 2025

Mar 17, 2025

Cellectar Biosciences Enhances CEO and COO Severance Benefits - TipRanks

Mar 17, 2025

Mar 17, 2025

What is Roth Capital’s Estimate for CLRB FY2029 Earnings? - Defense World

Mar 17, 2025

Mar 14, 2025

Earnings call transcript: Cellectar Biosciences Q4 2024 sees restructuring amid losses - Investing.com Australia

Mar 14, 2025

Mar 14, 2025

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 14, 2025

Mar 14, 2025

Cellectar Biosciences Inc (CLRB) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ... - Yahoo Finance

Mar 14, 2025

Mar 14, 2025

Cellectar Biosciences Inc (CLRB) Q4 2024 Earnings Call Highlight - GuruFocus

Mar 14, 2025

Mar 14, 2025

Cellectar Biosciences Faces Financial and Legal Turmoil Amidst Restated Earnings - TipRanks

Mar 14, 2025

Mar 14, 2025

Cellectar Biosciences Advances Cancer Drug Pipeline - TipRanks

Mar 14, 2025

Mar 13, 2025

Cellectar Biosciences Earnings Call: Mixed Outlook Amid Successes and Challenges - TipRanks

Mar 13, 2025

Mar 13, 2025

Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update - GlobeNewswire

Mar 13, 2025

Mar 13, 2025

CELLECTAR BIOSCIENCES Earnings Results: $CLRB Reports Quarterly Earnings | CLRB Stock News - Quiver Quantitative

Mar 13, 2025

Mar 13, 2025

Cellectar's Breakthrough: 83.6% Response Rate Puts FDA Fast Track Within Reach - StockTitan

Mar 13, 2025

Mar 13, 2025

Cellectar Biosciences Provides Update on FDA Regulatory Path for Iopofosine I 131 in Waldenström Macroglobulinemia and Advances Phase 1 Trials for New Radioconjugates - Nasdaq

Mar 13, 2025

Mar 13, 2025

Cellectar Biosciences COO acquires $8,400 in stock By Investing.com - Investing.com Canada

Mar 13, 2025

Mar 12, 2025

Cellectar Biosciences COO acquires $8,400 in stock - Investing.com India

Mar 12, 2025

Mar 11, 2025

Cellectar Biosciences to Present at the 37th Annual Roth Conference - Quantisnow

Mar 11, 2025

Mar 11, 2025

Cellectar Biosciences Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Mar 11, 2025

Mar 11, 2025

Cellectar Biosciences, Inc. to Present at 37th Annual Roth Conference - Nasdaq

Mar 11, 2025

Mar 11, 2025

Cancer Treatment Breakthrough? Cellectar Biosciences Reveals Latest Progress at Major Investor Conference - StockTitan

Mar 11, 2025

Mar 10, 2025

Before You Invest, Make Sure You Check This Cellectar Biosciences Inc (NASDAQ: CLRB) Analysis - stocksregister.com

Mar 10, 2025

Mar 10, 2025

Cellectar Biosciences (NASDAQ:CLRB) Now Covered by Analysts at StockNews.com - Defense World

Mar 10, 2025

Mar 08, 2025

Cellectar Biosciences (CLRB) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 08, 2025

Mar 05, 2025

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025 - GlobeNewswire

Mar 05, 2025